VIRUS-ASSOCIATED TUMORS

Clinical trials for VIRUS-ASSOCIATED TUMORS explained in plain language.

Never miss a new study

Get alerted when new VIRUS-ASSOCIATED TUMORS trials appear

Sign up with your email to follow new studies for VIRUS-ASSOCIATED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New Triple-Threat attack on tough cancers enters major trial

Disease control Recruiting now

This study is testing a combination of three treatments—an immunotherapy drug (atezolizumab), a new immune-stimulating drug (BDB001), and targeted radiation—to see if they can better control advanced solid tumors. It is enrolling 247 adults with specific advanced cancers, includi…

Matched conditions: VIRUS-ASSOCIATED TUMORS

Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

VIRUS-ASSOCIATED TUMORS

Get alerted when new VIRUS-ASSOCIATED TUMORS trials appear

New Triple-Threat attack on tough cancers enters major trial